Event
Bioengineering Seminar Series: James Wilson
Friday, October 21, 2011
11:00 a.m.
Room 1200 Jeong H. Kim Engineering Bldg.
Professor Silvia Muro
muro@umd.edu
Engineering of Vectors for Gene Therapy
James Wilson, M.D., Ph.D.
Director, Gene Therapy Program
Professor, Department of Pathology & Laboratory Medicine
Division of Transfusion Medicine
University of Pennsylvania School of Medicine
Dr. James M. Wilson is the Professor and Director of the Gene Therapy Program in the Department of Pathology and Laboratory Medicine, and Professor in the Department of Internal Medicine at the University of Pennsylvania. He received his undergraduate degree from Albion College with a B.S. in Chemistry and his M.D. and Ph.D. from the University of Michigan. Following a residency in Internal Medicine at the Harvard affiliated Massachusetts General Hospital and a postdoctoral fellowship at MIT, he returned to the University of Michigan where he took his first faculty position beginning his studies in gene therapy. Nineteen years ago, he moved his laboratory and family to Philadelphia and joined the faculty of the University of Pennsylvania. His research interests are gene therapy, genetic diseases, virology and vaccines for infectious diseases. A primary focus of his research has been the study of cystic fibrosis and development of new treatments based on gene therapy. Dr. Wilson has published over 497 papers and chapters in books and is on the editorial board of 12 scientific journals, serving as Editor-in-Chief of Human Gene Therapy. He is the former president of the American Society of Gene Therapy and former trustee of Albion College and the Franklin Institute.
